title: Treatment with neuromuscular blocking agents and the risk of in-hospital mortality among mechanically ventilated patients with severe sepsis.
abstract: OBJECTIVE
  Recent trials suggest that treatment with neuromuscular blocking agents may improve survival in patients requiring mechanical ventilation for acute respiratory distress syndrome. We examined the association between receipt of a neuromuscular blocking agent and in-hospital mortality among mechanically ventilated patients with severe sepsis.
  
  
  METHODS
  A pharmacoepidemiologic cohort study of patients with sepsis and a respiratory infection who had been admitted to intensive care and placed on mechanical ventilation within the first 2 days of hospitalization. We used propensity score matching and instrumental variable methods to compare the outcomes of patients treated with neuromuscular blocking agents within the first 2 hospital days to those who were not. Sensitivity analysis was used to model the effects of a hypothetical unmeasured confounder.
  
  
  METHODS
  Three hundred thirty-nine U.S. hospitals that participated in the Premier Perspective database between 2004 and 2006.
  
  
  METHODS
  Seven thousand eight hundred sixty-four patients met inclusion criteria, including 1,818 (23%) who were treated with a neuromuscular blocking agent by hospital day 2.
  
  
  METHODS
  None.
  
  
  RESULTS
  Patients who received neuromuscular blocking agents were younger (mean age, 62 vs 68), more likely to be treated with vasopressors (69% vs 65%) and had a lower in-hospital mortality rate (31.9% vs 38.3%, p < 0.001). In 3,518 patients matched on the propensity for treatment, receipt of a neuromuscular blocking agent was associated with a reduced risk of in-hospital mortality (risk ratio, 0.88; 95% CI, 0.80, 0.96). An analysis using the hospital neuromuscular blocking agent-prescribing rate as an instrumental variable found receipt of a neuromuscular blocking agent associated with a 4.3% (95% CI, -11.5%, 1.5%) reduction in in-hospital mortality.
  
  
  CONCLUSIONS
  Among mechanically ventilated patients with severe sepsis and respiratory infection, early treatment with a neuromuscular blocking agent is associated with lower in-hospital mortality.
authors: 1Division of Pulmonary and Critical Care Medicine, Baystate Medical Center, Springfield, MA. 2Department of Medicine, Tufts University School of Medicine, Boston, MA. 3Center for Quality of Care Research, Baystate Medical Center, Springfield, MA. 4Division of General Medicine, Baystate Medical Center, Springfield, MA. 5Department of Medicine, Medicine Institute, Cleveland Clinic, Cleveland, OH. 6OptiStatim, LLC, Longmeadow, MA. 7Department of Anesthesiology, Duke University Medical Center Anesthesiology Service, Durham VA Medical Center, Durham, NC.
authors: Jay S
authors: JS
authors: Steingrub
authors: Tara
authors: T
authors: Lagu
authors: Michael B
authors: MB
authors: Rothberg
authors: Brian H
authors: BH
authors: Nathanson
authors: Karthik
authors: K
authors: Raghunathan
authors: Peter K
authors: PK
authors: Lindenauer
mesh_terms: D000368:Aged; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D009466:Neuromuscular Blocking Agents / Q000627:therapeutic use*; D057216:Propensity Score; D012121:Respiration, Artificial / Q000401:mortality*; D012189:Retrospective Studies; D012307:Risk Factors; D018805:Sepsis / Q000188:drug therapy / Q000401:mortality* / Q000628:therapy
chemical_list: D009466:Neuromuscular Blocking Agents
references: Am J Epidemiol. 2008 Feb 15;167(4):492-9
references: 18056625
references: Crit Care Med. 2011 Nov;39(11):2425-30
references: 22005222
references: Biometrics. 1998 Sep;54(3):948-63
references: 9750244
references: N Engl J Med. 2005 Dec 1;353(22):2335-41
references: 16319382
references: Crit Care Med. 2002 Jan;30(1):142-56
references: 11902255
references: N Engl J Med. 2010 Sep 16;363(12):1176-80
references: 20843254
references: Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):537-54
references: 20354968
references: Curr Opin Crit Care. 2009 Feb;15(1):59-66
references: 19186410
references: Br J Anaesth. 2003 Jul;91(1):106-19
references: 12821570
references: JAMA. 2007 Jan 17;297(3):278-85
references: 17227979
references: N Engl J Med. 2010 Sep 16;363(12):1107-16
references: 20843245
references: Lancet. 1996 Jun 8;347(9015):1579-82
references: 8667865
references: Intensive Crit Care Nurs. 2003 Dec;19(6):350-62
references: 14637295
references: Am J Epidemiol. 2006 Feb 1;163(3):262-70
references: 16371515
references: Stat Med. 2007 Feb 20;26(4):734-53
references: 16708349
references: JAMA. 2002 Dec 11;288(22):2859-67
references: 12472328
references: Chest. 2005 Aug;128(2):496-506
references: 16100131
references: Am J Respir Crit Care Med. 2001 Apr;163(5):1059-63
references: 11316635
references: N Engl J Med. 2003 Apr 17;348(16):1546-54
references: 12700374
references: Pediatr Crit Care Med. 2002 Apr;3(2):129-133
references: 12780981
references: Crit Care Med. 2006 Nov;34(11):2749-57
references: 16932229
references: Crit Care Med. 2006 Feb;34(2):374-80
references: 16424717
references: JAMA. 1994 Sep 21;272(11):859-66
references: 8078163